News, Analysis & Insights on Nutrition, Supplements, and Health
A breakdown in communication between Beehive Botanicals and its GMP certifier NSF International created the situation in which Beehive received an FDA Warning Letter over GMP violations. And, from Beehive’s point of view, receiving a favorable judgment...
Abattis Bioceuticals Corp. has signed a letter of intent to produce in the US kombucha infused with cannabidiol (CBD), a non-narcotic compound derived from marijuana, the company announced yesterday.
The European soy sector says a UN report that found dairy proteins offer a superior amino acid profile to plant proteins is only meaningful for the malnourished.
Adding vitamin supplements to antipsychotic medication may help to alleviate certain negative symptoms in people who suffer from schizophrenia, researchers suggest.
Diets rich in cocoa may help people with diabetes to regulate insulin levels, according to new research.
Omega Protein CEO Bret Scholtes said the company is looking toward organic growth first in the wake of its acquisition of whey producer Wisconsin Specialty Protein. But doesn’t mean the company isn’t ready to pull the trigger if the right deal comes along.
New York State Senate Majority Coalition Leader Jeff Klein is seeking to ban the sale of products containing the controversial ingredient DMAA (dimethylamylamine) in the Empire State.
The chairman of the Chicago City Council committee discussing highly caffeinated energy drinks is ‘confident’ some sort of action will come out of the hearings.
Better food fortification initiatives are required to tackle the global problem of hidden hunger that accounts for 10% of health costs, a Nestlé-sponsored congress heard in Germany today.
In just the first weekend of new regulations designed to prohibit the trafficking of infant formula out of Hong Kong, border patrols had already arrested around 45 traders.
FDA enforcement of the current good manufacturing practices (cGMP) regulations is ‘a huge opportunity for the dietary supplements market’, says Frank Jaksch, CEO of Chromadex.